Search Results - Rayner, Emma
- Showing 1 - 20 results of 25
- Go to Next Page
-
1
A Novel Vaccine against Crimean-Congo Haemorrhagic Fever Protects 100% of Animals against Lethal Challenge in a Mouse Model by Buttigieg, Karen R., Dowall, Stuart D., Findlay-Wilson, Stephen, Miloszewska, Aleksandra, Rayner, Emma, Hewson, Roger, Carroll, Miles W.
Published 2014Text -
2
Lineage-dependent differences in the disease progression of Zika virus infection in type-I interferon receptor knockout (A129) mice by Dowall, Stuart D., Graham, Victoria A., Rayner, Emma, Hunter, Laura, Atkinson, Barry, Pearson, Geoff, Dennis, Mike, Hewson, Roger
Published 2017Text -
3
Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses by Dowall, Stuart D., Graham, Victoria A., Rayner, Emma, Hunter, Laura, Watson, Robert, Taylor, Irene, Rule, Antony, Carroll, Miles W., Hewson, Roger
Published 2016Text -
4
-
5
TNFα promotes CAR-dependent migration of leukocytes across epithelial monolayers by Morton, Penny E., Hicks, Alexander, Ortiz-Zapater, Elena, Raghavan, Swetavalli, Pike, Rosemary, Noble, Alistair, Woodfin, Abigail, Jenkins, Gisli, Rayner, Emma, Santis, George, Parsons, Maddy
Published 2016Text -
6
Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig model by Dowall, Stuart D., Bosworth, Andrew, Watson, Robert, Bewley, Kevin, Taylor, Irene, Rayner, Emma, Hunter, Laura, Pearson, Geoff, Easterbrook, Linda, Pitman, James, Hewson, Roger, Carroll, Miles W.
Published 2015Text -
7
Finafloxacin, a Novel Fluoroquinolone, Reduces the Clinical Signs of Infection and Pathology in a Mouse Model of Q Fever by Hartley, M. Gill, Norville, Isobel H., Richards, Mark I., Barnes, Kay B., Bewley, Kevin R., Vipond, Julia, Rayner, Emma, Vente, Andreas, Armstrong, Stuart J., Harding, Sarah V.
Published 2021Text -
8
Post-exposure treatment of non-human primates lethally infected with Ebola virus with EBOTAb, a purified ovine IgG product by Dowall, Stuart D., Jacquot, Frédéric, Landon, John, Rayner, Emma, Hall, Graham, Carbonnelle, Caroline, Raoul, Hervé, Pannetier, Delphine, Cameron, Ian, Coxon, Ruth, Al Abdulla, Ibrahim, Hewson, Roger, Carroll, Miles W.
Published 2017Text -
9
Post-exposure treatment of Ebola virus disease in guinea pigs using EBOTAb, an ovine antibody-based therapeutic by Dowall, Stuart D., Bosworth, Andrew, Rayner, Emma, Taylor, Irene, Landon, John, Cameron, Ian, Coxon, Ruth, Al Abdulla, Ibrahim, Graham, Victoria A., Hall, Graham, Kobinger, Gary, Hewson, Roger, Carroll, Miles W.
Published 2016Text -
10
Protective Efficacy of Inhaled BCG Vaccination Against Ultra-Low Dose Aerosol M. tuberculosis Challenge in Rhesus Macaques by White, Andrew D., Sarfas, Charlotte, Sibley, Laura S., Gullick, Jennie, Clark, Simon, Rayner, Emma, Gleeson, Fergus, Català, Martí, Nogueira, Isabel, Cardona, Pere-Joan, Vilaplana, Cristina, Dennis, Mike J., Williams, Ann, Sharpe, Sally A.
Published 2020Text -
11
DNA-Vaccine-Induced Immune Response Correlates with Lower Viral SARS-CoV-2 Titers in a Ferret Model by Compagnone, Mirco, Pinto, Eleonora, Salvatori, Erika, Lione, Lucia, Conforti, Antonella, Marchese, Silvia, Ravà, Micol, Ryan, Kathryn, Hall, Yper, Rayner, Emma, Salguero, Francisco J., Paterson, Jemma, Iannacone, Matteo, De Francesco, Raffaele, Aurisicchio, Luigi, Palombo, Fabio
Published 2022Text -
12
Sequential delivery of LAIV and SARS-CoV-2 in the ferret model can reduce SARS-CoV-2 shedding and does not result in enhanced lung pathology by Ryan, Kathryn A, Schewe, Katarzyna E, Crowe, Jonathan, Fotheringham, Susan A, Hall, Yper, Humphreys, Richard, Marriott, Anthony C, Paterson, Jemma, Rayner, Emma, Salguero, Francisco J, Watson, Robert J, Whittaker, Catherine J, Carroll, Miles W, Dibben, Oliver
Published 2021Text -
13
Development of a Cost-effective Ovine Polyclonal Antibody-Based Product, EBOTAb, to Treat Ebola Virus Infection by Dowall, Stuart David, Callan, Jo, Zeltina, Antra, Al-Abdulla, Ibrahim, Strecker, Thomas, Fehling, Sarah K., Krähling, Verena, Bosworth, Andrew, Rayner, Emma, Taylor, Irene, Charlton, Sue, Landon, John, Cameron, Ian, Hewson, Roger, Nasidi, Abdulsalami, Bowden, Thomas A., Carroll, Miles W.
Published 2016Text -
14
Non-Replicating Mycobacterium tuberculosis Elicits a Reduced Infectivity Profile with Corresponding Modifications to the Cell Wall and Extracellular Matrix by Bacon, Joanna, Alderwick, Luke J., Allnutt, Jon A., Gabasova, Evelina, Watson, Robert, Hatch, Kim A., Clark, Simon O., Jeeves, Rose E., Marriott, Alice, Rayner, Emma, Tolley, Howard, Pearson, Geoff, Hall, Graham, Besra, Gurdyal S., Wernisch, Lorenz, Williams, Ann, Marsh, Philip D.
Published 2014Text -
15
MTBVAC vaccination protects rhesus macaques against aerosol challenge with M. tuberculosis and induces immune signatures analogous to those observed in clinical studies by White, Andrew D., Sibley, Laura, Sarfas, Charlotte, Morrison, Alexandra, Gullick, Jennie, Clark, Simon, Gleeson, Fergus, McIntyre, Anthony, Arlehamn, Cecilia Lindestam, Sette, Alessandro, Salguero, Francisco J., Rayner, Emma, Rodriguez, Esteban, Puentes, Eugenia, Laddy, Dominick, Williams, Ann, Dennis, Mike, Martin, Carlos, Sharpe, Sally
Published 2021Text -
16
Low Dose Influenza Virus Challenge in the Ferret Leads to Increased Virus Shedding and Greater Sensitivity to Oseltamivir by Marriott, Anthony C., Dove, Brian K., Whittaker, Catherine J., Bruce, Christine, Ryan, Kathryn A., Bean, Thomas J., Rayner, Emma, Pearson, Geoff, Taylor, Irene, Dowall, Stuart, Plank, Jenna, Newman, Edmund, Barclay, Wendy S., Dimmock, Nigel J., Easton, Andrew J., Hallis, Bassam, Silman, Nigel J., Carroll, Miles W.
Published 2014Text -
17
High-dose Mycobacterium tuberculosis aerosol challenge cannot overcome BCG-induced protection in Chinese origin cynomolgus macaques; implications of natural resistance for vaccine... by Sibley, Laura, White, Andrew D., Gooch, Karen E., Stevens, Lisa M., Tanner, Rachel, Jacobs, Ashley, Daykin-Pont, Owen, Gleeson, Fergus, McIntyre, Anthony, Basaraba, Randall, Clark, Simon, Hall, Graham, Pearson, Geoff, Rayner, Emma, McShane, Helen, Williams, Ann, Dennis, Mike, Marsh, Philip D., Sharpe, Sally
Published 2021Text -
18
Development of a cost-effective ovine antibody-based therapy against SARS-CoV-2 infection and contribution of antibodies specific to the spike subunit proteins by Findlay-Wilson, Stephen, Easterbrook, Linda, Smith, Sandra, Pope, Neville, Humphries, Gareth, Schuhmann, Holger, Ngabo, Didier, Rayner, Emma, Otter, Ashley David, Coleman, Tom, Hicks, Bethany, Graham, Victoria Anne, Halkerston, Rachel, Apostolakis, Kostis, Taylor, Stephen, Fotheringham, Susan, Horton, Amanda, Tree, Julia Anne, Wand, Matthew, Hewson, Roger, Dowall, Stuart David
Published 2022Text -
19
Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored Vaccines by López-Camacho, César, De Lorenzo, Giuditta, Slon-Campos, Jose Luis, Dowall, Stuart, Abbink, Peter, Larocca, Rafael A., Kim, Young Chan, Poggianella, Monica, Graham, Victoria, Findlay-Wilson, Stephen, Rayner, Emma, Carmichael, Jennifer, Dejnirattisai, Wanwisa, Boyd, Michael, Hewson, Roger, Mongkolsapaya, Juthathip, Screaton, Gavin R., Barouch, Dan H., Burrone, Oscar R., Patel, Arvind H., Reyes-Sandoval, Arturo
Published 2020Text -
20
Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model by Proud, Pamela C., Tsitoura, Daphne, Watson, Robert J., Chua, Brendon Y., Aram, Marilyn J., Bewley, Kevin R., Cavell, Breeze E., Cobb, Rebecca, Dowall, Stuart, Fotheringham, Susan A., Ho, Catherine M.K., Lucas, Vanessa, Ngabo, Didier, Rayner, Emma, Ryan, Kathryn A., Slack, Gillian S., Thomas, Stephen, Wand, Nadina I., Yeates, Paul, Demaison, Christophe, Zeng, Weiguang, Holmes, Ian, Jackson, David C., Bartlett, Nathan W., Mercuri, Francesca, Carroll, Miles W.
Published 2020Text